Doctor Muhammad Nadeem Aslam, an assistant research scientist in the Department of Pathology at the University of Michigan, told Medical News Today: “One of the effects Aquamin has shown in this study is a significant decrease in collagen deposition, which usually represents fibrosis.
“Decrease in fibrosis will cause less tissue damage and decreases progression toward end-stage effects of liver injury.”
Earlier research has highlighted the benefits of blue-tree algae in preventing non-alcoholic fatty liver disease.
Similarly, the blue-tree algae have been shown to drive a reduction in inflammation, hyperlipidemia and oxidative stress, helping prevent fatty liver disease and cancer.
